Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label study of dronedarone on quality of life in non-permanent atrial fibrillation
2010-018976-25Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dronedarone in Atrial fibrillation (AFib), sponsored by Sanofi. Primary endpoint: Change in SF-36 Physical Component Summary score at 3 months. Started Jun 2010; status: completed.
02
Drugs
dronedarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2010-018976-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018976-25.